Key Takeaways

• InnerPlant has completed the FDA’s New Protein Consultation for its InnerSoy product, marking a regulatory achievement.
• The InnerSoy product helps soybean plants signal early signs of fungal stress through fluorescent signals visible from afar.
• The company aims to expand its CropVoice alert system in the Midwest and plans further geographical expansion by 2026.

Regulatory Milestone Achieved

InnerPlant, a seed technology company based in the US, has announced a significant milestone in its regulatory journey by completing the FDA’s New Protein Consultation (NPC) for the fluorescent protein utilized in its InnerSoy product. Shely Aronov, the CEO and cofounder, described this achievement as “a meaningful step forward in our regulatory pathway providing support for the safety of our science.”

InnerPlant focuses on genetically engineering plants to emit fluorescent signals when they experience distress from diseases, pests, or environmental stressors. These “sensor plants” can reportedly display fluorescent colors that are visible from miles away, even from space. Specifically, the InnerSoy product is designed to signal fungal pressure in soybean plants, triggering a fluorescent response at the earliest signs of fungal stress, thus enabling timely intervention.

The completion of the FDA consultation is particularly important, as it assesses the safety of non-pesticidal proteins produced by new plant varieties intended for food usage. Aronov emphasized the significance of navigating the regulatory landscape, stating this step is crucial for “unlocking the full potential of every InnerPlant trait.”

In addition to FDA progress, InnerPlant has also achieved USDA approval in 2023. This combination of regulatory approvals creates a strong foundation as the company strives toward global regulatory acceptance of its products. Moving forward, Aronov expressed excitement about a future where InnerPlant’s sensors could be incorporated into every field, enhancing the effectiveness and efficiency of farming practices.

Last year, InnerPlant secured $30 million in a Series B funding round, with investments coming from Deere & Company and a consortium of major North American growers. This funding is partly allocated towards the rollout of CropVoice, an insights platform designed to provide critical agricultural information to farmers.

Going ahead, the immediate focus for InnerPlant is to expand its CropVoice fungal alert network to farmers in key Midwestern states such as Illinois, Iowa, and Nebraska. Aronov highlighted that the company has established several key partnerships with retailers, which will be unveiled soon. Additionally, InnerPlant is already planning to broaden its presence into new geographical areas by 2026.

By advancing its regulatory approvals and expanding its technical capabilities, InnerPlant is setting the stage for a revolutionary approach to agriculture, which leverages technology to improve crop health and farming efficiency.

The content above is a summary. For more details, see the source article.